Brain cancer prediction has taken a significant leap forward with the advent of artificial intelligence (AI) technologies that enhance our ability to anticipate relapse risks in pediatric patients.A groundbreaking study from Harvard showcased how AI tools outperform traditional methods by analyzing sequential brain scans, particularly for conditions like pediatric gliomas.